Prevention & care

Sheehan syndrome: postpartum pituitary injury, immediate and delayed symptoms, hormone assessment, replacement, and recovery questions

9 sources · Latest source check 2026-10-09 UTC

On this page

Sheehan syndrome is pituitary tissue injury associated with severely reduced blood supply around childbirth, classically after major bleeding and shock. It can cause loss of several hormone functions or only some. This is a specific cause of hypopituitarism, not a diagnosis for ordinary postpartum fatigue or every breastfeeding difficulty.[1]

Blood-flow injury differs from autoimmune inflammation

Pregnancy changes pituitary size and physiology. The August 2025 Endotext chapter describes ischemic necrosis after postpartum hemorrhage, hypotension and shock. Inflammation such as lymphocytic hypophysitis and other pituitary problems can also occur around pregnancy. The obstetric history, hormone pattern and structural assessment help clinicians distinguish causes; a postpartum date alone cannot select the diagnosis.[1]

Several hormone pathways may be affected

Several hormone pathways may be affected
Pathway	Relevant function
ACTH to adrenal cortisol	Illness response, blood pressure and glucose regulation.[2]
TSH to thyroid hormones	Metabolic and temperature-related function.[5]
LH/FSH to ovarian function	Menstrual, sexual and fertility-related function.[2]
Prolactin and growth hormone	Milk production and tissue/growth-related functions; deficiencies have distinct implications.[2]

Some presentations are immediate medical emergencies

Persistent low blood pressure, vomiting, low blood glucose or deterioration after severe obstetric bleeding can raise concern even after initial resuscitation. Suspected adrenal failure requires urgent clinical treatment rather than waiting for every pituitary test. Severe ongoing bleeding, collapse or altered consciousness needs emergency help; this page supplies no home diagnostic or treatment procedure.[1]

Recognition can occur years after childbirth

A French reference-center study examined 39 diagnosed women from 1980–2011 and reported a mean diagnostic delay of nine years. Symptoms included fatigue, absent menstruation, thyroid-related problems and acute adrenal insufficiency. Records were incomplete for some features. The finding demonstrates missed-recognition potential in that cohort, not that every affected person waits nine years or that postpartum symptoms usually represent Sheehan syndrome.[6]

Milk-production history can be a clue without becoming a stand-alone test

The French study highlights failure to lactate after significant postpartum hemorrhage as a reason to consider endocrine evaluation. Feeding choices, access to support and other causes of low milk supply affect the history. Absence of one symptom cannot comprehensively exclude partial disease, and difficulty breastfeeding alone is not proof of pituitary necrosis.[6]

Partial function and later change both matter

A 2014 retrospective Turkish cohort of 114 diagnosed patients found partial hypopituitarism in 44.7% and more extensive deficiency in 55.3% at recognition. The investigators also observed increasing deficient pathways over time. Their selected population and historical care context limit generalization. Continued function of one pathway does not guarantee adequate function of all the others.[7]

Assessment looks at signaling, target hormones and clinical timing

The 2016 disease primer describes diagnosis through clinical history, manifestations and hormone assessment, sometimes with stimulation tests. Pituitary and target-organ hormones answer different questions. A general hormone score cannot by itself establish the cause or determine every replacement need.[3]

Central thyroid deficiency needs a different interpretation

The 2025 review explains that free T4 guides central-thyroid replacement assessment rather than relying on TSH alone. It also emphasizes assessing or treating adrenal insufficiency before starting thyroid replacement. The sequence is a clinical safety issue; this explanation does not advise independently starting, withholding or adjusting either prescription.[5]

An empty-sella appearance is a description, not a complete diagnosis

MedlinePlus explains that an “empty sella” is an imaging appearance associated with a flattened or reduced pituitary within its bony compartment; the space is not literally empty. Primary and secondary causes exist, and function may be preserved in some people. The image therefore does not by itself prove childbirth-related injury, identify all deficient hormones or indicate treatment.[4]

Treatment targets demonstrated deficient functions

Replacement addresses deficient functions, not regrowth of necrotic tissue. Different hormone deficits need different assessment and care. The 2016 primer presents hormone replacement as management; newer symptom-focused trials do not invalidate that framework.[3]

Care extends beyond correcting one laboratory number

The contemporary review discusses bone, cardiovascular, cognitive and psychological burdens, as well as limitations of current replacement in mimicking normal physiology. Sex-hormone and growth-hormone decisions have individual eligibility and monitoring considerations. These associations do not establish that each additional hormone universally improves every outcome or that replacement guarantees complete symptom resolution.[5]

Preventing and treating severe bleeding is a health-system priority

The WHO/FIGO/ICM October 2025 consolidated postpartum-hemorrhage guideline addresses prevention, diagnosis and treatment; WHO also issued an implementation guide in February 2026. These documents concern maternal bleeding care. Their existence does not directly quantify how much a particular intervention reduces later Sheehan syndrome, and rapid bleeding care does not replace subsequent assessment of persistent endocrine symptoms.[9]

Evidence & uncertainty

Recognizing deficient hormones and providing appropriate replacement are established care. The frequency, diagnostic delay and longer-term burden vary across populations; selected clinic cohorts do not provide a universal incidence. Evidence for additional treatments and patient-important outcomes is less complete than the basic replacement framework.[5][6]

Selected-source overview · Independent review pending

Published questions

Is Sheehan syndrome a name for all postpartum fatigue?

Selected-source overview · Independent review pending. Read the evidence context.

It is a specific childbirth-associated pituitary injury.[1]

Evidence behind this answer

Pituitary and Adrenal Disorders of Pregnancy
clinical reference chapter · 2025
Original indexed relevant chapter passages inspected · August 22, 2025: pregnancy physiology, ischemic injury and acute/delayed presentation